Credit Suisse Maintains Underperform on Masco, Raises Price Target to $45
Credit Suisse analyst Dan Oppenheim maintains Masco (NYSE:MAS) with a Underperform and raises the price target from $40 to $45.
RBC Capital Upgrades Masco to Outperform, Raises Price Target to $57
RBC Capital analyst Mike Dahl upgrades Masco (NYSE:MAS) from Sector Perform to Outperform and raises the price target from $49 to $57.
Keybanc Maintains Overweight on Masco, Lowers Price Target to $62
Keybanc analyst Kenneth Zener maintains Masco (NYSE:MAS) with a Overweight and lowers the price target from $66 to $62.
Earnings Scheduled For February 9, 2023
Companies Reporting Before The Bell
• AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion.
Masco Corporation Reaches $5M Milestone In Grant Program Aimed At Driving Diversity, Equity And Inclusion In Workplaces
Grant Program has Supported over 140 Organizations Nationwide
Masco Corporation is pleased to announce that through its Masco Million Differences campaign it has cumulatively made $5 million in cash donations
RBC Capital Downgrades Masco to Sector Perform, Lowers Price Target to $47
RBC Capital analyst Mike Dahl downgrades Masco (NYSE:MAS) from Outperform to Sector Perform and lowers the price target from $57 to $47.
Deutsche Bank Maintains Hold on Masco, Lowers Price Target to $55
Deutsche Bank analyst Joe Ahlersmeyer maintains Masco (NYSE:MAS) with a Hold and lowers the price target from $61 to $55.
Expert Ratings for Masco
Within the last quarter, Masco (NYSE:MAS) has observed the following analyst ratings:
Masco Earnings Perspective: Return On Invested Capital
According to Benzinga Pro, during Q2, Masco (NYSE:MAS) earned $294.00 million, a 16.67% increase from the preceding quarter. Masco also posted a total of $2.35 billion in sales, a 6.86% increase since Q1.